Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julius Nikorowitsch

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
JACC. Case Reports|September 25, 2025
Leadless Pacing and Cardioversion: Power On or Power Off?Roland Tilz, Julius Nikorowitsch, Anna Traub
Biomolecules|March 8, 2020
Head-to-Head Comparison of the Incremental Predictive Value of The Three Established Risk Markers, Hs-troponin I, C-Reactive Protein, and NT-proBNP, in Coronary Artery DiseaseJulius Nikorowitsch, Francisco Ojeda, Karl J Lackner, et al.
The International Journal of Cardiovascular Imaging|July 7, 2021
Aortic root dimensions as a correlate for aortic regurgitation's severityJan-Per Wenzel, Elina Petersen, Julius Nikorowitsch, et al.
Heart Rhythm O2|February 25, 2026
"Awake and Ablated": First experience with a balloon-in-basket PFA system without propofolRoland Richard Tilz, Jan-Per Wenzel, Charlotte Eitel, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 16, 2021
Diastolic dysfunction in individuals with and without heart failure with preserved ejection fractionJan-Per Wenzel, Ramona Bei der Kellen, Christina Magnussen, et al.
Journal of the American Heart Association|April 18, 2020
Cardio-Renal Biomarker Soluble Urokinase-Type Plasminogen Activator Receptor Is Associated With Cardiovascular Death and Myocardial Infarction in Patients With Coronary Artery Disease Independent of Troponin, C-Reactive Protein, and Renal FunctionJulius Nikorowitsch, Tim Borchardt, Sebastian Appelbaum, et al.
ESC Heart Failure|August 30, 2021
Applying the ESC 2016, H<sub>2</sub> FPEF, and HFA-PEFF diagnostic algorithms for heart failure with preserved ejection fraction to the general populationJulius Nikorowitsch, Ramona Bei der Kellen, Paulus Kirchhof, et al.
The International Journal of Cardiovascular Imaging|July 29, 2021
Transthoracic echocardiographic reference values of the aortic root: results from the Hamburg City Health StudyJan-Per Wenzel, Elina Petersen, Julius Nikorowitsch, et al.
Biomolecules|March 21, 2019
Diagnostic Value of Soluble Urokinase-Type Plasminogen Activator Receptor in Addition to High-Sensitivity Troponin I in Early Diagnosis of Acute Myocardial InfarctionNils A Sörensen, Günay Dönmez, Johannes T Neumann, et al.
ESC Heart Failure|April 21, 2022
Heart failure in the general population and impact of the 2021 European Society of Cardiology Heart Failure GuidelinesJan-Per Wenzel, Julius Nikorowitsch, Ramona Bei der Kellen, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
JACC. Case Reports|September 25, 2025
Leadless Pacing and Cardioversion: Power On or Power Off?Roland Tilz, Julius Nikorowitsch, Anna Traub
Biomolecules|March 8, 2020
Head-to-Head Comparison of the Incremental Predictive Value of The Three Established Risk Markers, Hs-troponin I, C-Reactive Protein, and NT-proBNP, in Coronary Artery DiseaseJulius Nikorowitsch, Francisco Ojeda, Karl J Lackner, et al.
The International Journal of Cardiovascular Imaging|July 7, 2021
Aortic root dimensions as a correlate for aortic regurgitation's severityJan-Per Wenzel, Elina Petersen, Julius Nikorowitsch, et al.
Heart Rhythm O2|February 25, 2026
"Awake and Ablated": First experience with a balloon-in-basket PFA system without propofolRoland Richard Tilz, Jan-Per Wenzel, Charlotte Eitel, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 16, 2021
Diastolic dysfunction in individuals with and without heart failure with preserved ejection fractionJan-Per Wenzel, Ramona Bei der Kellen, Christina Magnussen, et al.
Journal of the American Heart Association|April 18, 2020
Cardio-Renal Biomarker Soluble Urokinase-Type Plasminogen Activator Receptor Is Associated With Cardiovascular Death and Myocardial Infarction in Patients With Coronary Artery Disease Independent of Troponin, C-Reactive Protein, and Renal FunctionJulius Nikorowitsch, Tim Borchardt, Sebastian Appelbaum, et al.
ESC Heart Failure|August 30, 2021
Applying the ESC 2016, H<sub>2</sub> FPEF, and HFA-PEFF diagnostic algorithms for heart failure with preserved ejection fraction to the general populationJulius Nikorowitsch, Ramona Bei der Kellen, Paulus Kirchhof, et al.
The International Journal of Cardiovascular Imaging|July 29, 2021
Transthoracic echocardiographic reference values of the aortic root: results from the Hamburg City Health StudyJan-Per Wenzel, Elina Petersen, Julius Nikorowitsch, et al.
Biomolecules|March 21, 2019
Diagnostic Value of Soluble Urokinase-Type Plasminogen Activator Receptor in Addition to High-Sensitivity Troponin I in Early Diagnosis of Acute Myocardial InfarctionNils A Sörensen, Günay Dönmez, Johannes T Neumann, et al.
ESC Heart Failure|April 21, 2022
Heart failure in the general population and impact of the 2021 European Society of Cardiology Heart Failure GuidelinesJan-Per Wenzel, Julius Nikorowitsch, Ramona Bei der Kellen, et al.
Pageof 3